Abstract
The lung is a heterogeneous organ, composed of morphologically different sub-compartments. When analyzing lung pathologies, it is important to collect the spatial location of lesions, to allow the translation of e.g. preclinical study results to the human lung, or the formulation of targeted treatment strategies. For the purpose of this review, bronchopulmonary dysplasia will serve as an example for a lung pathology to be studied, but the methods demonstrated can be adapted to other pathologies as well. The review’s focus will lie on common histological methods and the potential to use them for both the study of cellular features and location assessment. Morphological characteristics, as well as intracellular states related to cell cycle and cell death will be considered. In an advanced section, the combination of multiple imaging methods into analysis pipelines is detailed, describing different combinatorial possibilities with their advantages and use in the research context. Through the integration of microscopy and computed tomography into one process, it is possible to assess both 3D location and cellular features, with the option of employing immunohistochemical markers for the detection of specific proteins as well. This is a tool that can be used in addressing both transitional and longitudinal research questions regarding lung pathologies.
1 Introduction
Mammalian lungs have a highly heterogeneous architecture. The airways form a tree-like structure, branching out from the trachea down to the alveoli. During this course, they change in overall size, cellular composition and dimensions of the airway epithelium, as well as number of smooth muscle cell layers and presence of glands or supporting cartilage. The terminal bronchioles then mark the change from an air-conductive system, optimized for airflow, to a compartment optimized for gas diffusion. A similarly diverse structure is found in the vasculature, where dimensions and composition differ greatly between e.g. central pulmonary artery and the capillaries enveloping the alveoli (Weibel, 2009).
This multi-faceted organ composition leads to different levels of susceptibility to external stressors, implications of damage and presentation of lesions between sub-compartments of differing morpho-functional composition. It is therefore essential for the use of preclinical animal models of lung diseases, to determine the location of observed changes, both for the facilitation of adequate comparisons between e.g. treatment and control group, as well as for the translation of the results to the human lung. This article will focus on Bronchopulmonary dysplasia (BPD) as a source of lung damage, but the methods listed here are applicable to other lung pathologies as well.
BPD is a syndrome that affects infants born at an extremely preterm time point (< 28 weeks of gestation), when the lung is still in early stages of development, particularly the canalicular or early saccular phase. Necessary treatments such as mechanical ventilation and hyperoxia cause lung injury, potentially triggering a disruption in alveolarization and microvascular development (Thebaud et al., 2019).
On an organ level, the affected lung may present features such as large airway obstruction and small airway hyperinflation (), enlarged and simplified alveoli (), as well as simplification or arrested growth of the pulmonary vasculature ().
On a cellular level, the airways can exhibit morphological alterations like epithelial thickening (Tiddens et al., 2008), ciliary abnormalities (Lee and O’Brodovich, 1988) or an increased number of goblet cells and smooth muscle cells (). Smooth muscle cell proliferation is also a problem in the vasculature, where it can lead to pulmonary hypertension ().
The main driver for these changes is oxidative stress, for which the immature lung is especially susceptible, eventually leading to inflammation and programmed cell death (Kaarteenaho-Wiik and Kinnula, 2004; Wang and Dong, 2018). The premature infant’s antioxidant enzyme system is still underdeveloped. Hyperoxia increases reactive oxygen species (ROS) production in mitochondria and subsequent cellular buildup that causes stress and injury, potentially ending in apoptosis (). ROS buildup can also stimulate increased mucus secretion and pulmonary vasoconstriction (; Wright et al., 1994).
These changes are not evenly distributed throughout the lung. In a mouse model of hyperoxia, immunohistochemical detection of the tumor suppressor gene p53 showed its accumulation in the distal bronchial epithelial cells, as well as, to a lesser degree, in the alveolar epithelium. This demonstrates a local peak in reaction to oxidative stress, in the form of DNA-damage and subsequent cell cycle arrest, possibly leading to cell senescence or apoptosis as a result (O’Reilly et al.,1998).
Morphological studies on the pulmonary vasculature (Labode et al., 2023) and the airways (Pfleger et al., 2025) in a rabbit model of BPD were also able to demonstrate a heterogeneous distribution of differences between experimental- and control group. Affected sites could be attributed to specific levels of airway branching, displaying a diverse pathology that is not easily captured using purely global methods (i.e. when not recording or taking into account the site of the structure sampled).
The goal of this review is to present different methods for the identification of cellular alterations in the lung and their capabilities for providing spatial context for those loci of interest within the organ’s architecture. We will further present a novel extension for a multi-step imaging approach first established by , demonstrating the possibility of the location focused assessment of intracellular substance levels. The methods discussed here are aimed at preclinical small animal models. Application to human lung pathologies would require modifications to the presented workflows.
2 Light microscopy
2.1 Histological sections
The morphological study of histological lung sections through a light microscope is a central method in lung research (see e.g. Weibel, 1963; Ochs and Muhlfeld, 2013). It requires little expensive equipment and sample preparations can be performed in most laboratories. A wide range of staining protocols is available for marking features of interest. In preclinical models, that study small animals such as mice or rabbits, lungs can be harvested, embedded and whole lung slices can be placed on one microscopic glass slide to provide 2D spatial context. The achievable magnification of this technique is sufficient to study sub-cellular features (see e.g. Muhlfeld et al.,2021). An example is provided in Figure 1, where both a complete organ slice of a mouse lung, as well as a small airway cross section demonstrate the capabilities of this method.
Figure 1
Electron microscopy is able to achieve a significantly higher resolution, aiding the identification of intracellular changes, but in turn sacrifices field of view, i.e. spatial context (Ochs et al., 2016). Therefore, this method will not be discussed here any further.
Histological sections, even when only treated with standard stains, such as hematoxylin and eosin (HE) or toluidine blue, allow the collection of a wide variety of parameters relevant for identifying and quantifying pathological alterations. Examples include volumes and surface areas of various structures, epithelial changes, increases in smooth muscle mass or presence of fibrosis or inflammation. The use of a stereological counting scheme assures unbiased results (Muhlfeld and Ochs, 2013). Late-stage apoptosis can also be identified morphologically, by features such as membrane blebbing, nuclear condensation and formation of apoptotic vesicles (; Kumaraswamy et al., 2013). Care must however be taken during the organ fixation. As the lung is a highly dynamic organ, changing its shape during the breathing cycle, its morphology is highly dependent on the pressures applied to it. Thus, fixation must be performed under a physiological pressure setting, as pressures outside that range would lead to unrealistic organ presentations. Well-tuned setups however are able to fix the lung in specific physiological (e.g. inspiration or expiration) or pathophysiological inflation states (Perlman et al., 2024).
For intracellular processes, such as cell cycle arrest or early stages of apoptosis, immunohistochemical markers can be used to visualize involved proteins (; Xiao et al., 2015). An example would be activated caspase 3, that is present in cells undergoing apoptosis and its visualization can be used for quantification of affected cells ().
The inherent problem of LM however is, that single histological sections provide no 3D context. An airway cross-section in a LM image is not easily attributed to one specific branching order. The path through the organ, that connects this airway section to trachea and alveoli, is unknown. See e.g. the airway magnified in Figure 1. An approach to use LM to create this missing 3D context would be to produce serial sections of histological slices from the organ. This introduces a problem, as the tissue slice orientations on the glass slides will vary. Furthermore, the tissue might be stretched or compressed in the cutting process. To be able to stack them on top of one another to create a 3D representation of the organ, these inter slice differences would need to be removed. The solution to this problem is image registration (see e.g. ). Rigid registration algorithms will laterally move and rotate the tissue sections, while non-rigid algorithms will correct deformations. Slices can however be disturbed in the cutting and handling process in additional ways, that registration is unable to correct for adequately. Examples include tears, folds, major deformations, insufficient staining or complete slice loss. While there are mitigation strategies to limit the amount of deformations introduced during preparation (see e.g. Taqi et al., 2018), they are a common problem in computational histology (Kanwal et al., 2022). These artifacts can add up in the registration process and incrementally distort the images beyond usability. Thus, previous studies were only successful in reconstructing small stacks of histological slices (). Figure 2 exemplifies such damages. In comparison with other organs, the sparse tissue content of the lung seems to offer little structural integrity to withstand the shear forces encountered in the cutting process. Besides these problems, the amount of work to produce an image stack of a whole lung in a resolution high enough to study sub-cellular characteristics should be considered. At the usual 1 µm to 5 µm slice thickness, even an organ in the size range of a few millimeters will create hundreds of slices when completely sampled. Collecting only subsets instead, would result in losing the spatial context, i.e. connection between structures visible in the individual slice sub-stacks.
Figure 2
2.2 Light sheet fluorescence microscopy
A method that is capable of generating microscopic 3D datasets is light sheet fluorescence microscopy (LSFM). In this technique, only one plane of a volumetric specimen is illuminated by a sheet of light. Fluorescent dyes in the illuminated plane can thus be excited and captured by a microscope as a 2D image. By either moving the sample or the light source, the sheet of light can be moved. In this fashion, a series of 2D images along one axis of the sample can be collected and merged into a 3D image volume. In-vivo imaging is possible in small organisms (e.g. zebrafish, mouse embryos), but already at mouse size, only single explanted organs can be imaged at high resolution. The limiting factor here is the light scattering by the illuminated tissue. Size limitations can however be overcome to some extend by e.g. chemically clearing the tissue (see ; ). In lung research, this technique has been successfully employed e.g. by Yang et al. (2019) for mapping of the distribution of inhaled nanoparticles along the airways in an explanted mouse lung (see Figure 3a). While this method provides high magnification 3D data, the relianc.
Figure 3
2.3 Live tissue imaging
The methods detailed above suffer from one major limitation, that is, they are mostly limited to imaging a fixed tissue state, i.e. the cellular configuration of the organ at the time of fixation and embedding. For the study of e.g. pathogenesis and treatment response in real time, it is therefore either necessary to study living lung tissue in an ex-vivo setting or to perform the imaging in-vivo.
The oldest technique for investigations on live tissue in this context, is the use of precision cut lung slices (PCLS). For this method, an organ such as a fresh mouse lung is explanted, filled with agarose for stability and then cut into slices on a vibrating microtome. For larger animals or human tissue, biopsies are used instead of full organ cross sections. The slices, usually ranging between 100 µm to 500 µm in thickness, are then placed in a cell culture medium in well plates and can be studied for up to 14 days. In this state, there is no respiration or circulation present. However, there is still a plethora of processes that can be observed. Examples include airway contraction or relaxation as well as vasoconstriction and dilation, mucus secretion and ciliary motion, immune cell activation and mediator release or extracellular matrix deposition or degradation (see e.g. Koziol-White et al., 2024; Liu et al., 2019; Viana et al., 2021). The tissue cultures can be imaged using common microscopic techniques such as bright field or confocal microscopy and fluorescent imaging (see below). Live cell staining protocols are available (see e.g.
A method that overcomes limitations of PCLS, such as the lack of circulation and breathing motion, as well the missing option for a realistic treatment delivery (i.e. by inhalation or through the bloodstream), is the crystal ribcage. It consists of a mouse lung that is placed in a transparent model of a ribcage and is externally perfused and ventilated (see Figure 3b). The transparent housing permits optical imaging of most of the lung’s surface. Imaging depth ranges between 100 µm in air-filled alveoli and 500 µm in areas with reduced light scattering, such as edematous alveoli (see Figure 3c). This method excels at visualizing e.g. vascular transport of immune cells or alveolar cells in a sub-cellular resolution during simulated or induced physiological and pathophysiological states (see
The previous methods all used explanted lungs, creating an experimental setting that differs in various ways from the in-vivo situation. Intravital microscopy on the other hand captures microscopic images of an organ in-situ, preserving most of the natural organ surroundings. To achieve this, a window up to one centimeter in diameter is implanted into a mouse at a location in the thorax, where some ribs have been removed. The animal is anesthetized and ventilated during the procedure. Imaging can then be performed through the window in a similar fashion to the crystal ribcage, with the difference of a very limited field of view and a narrow time window for imaging, due to the ongoing narcosis (up to 3 hours have been reported). Imaging is further restricted to subpleural structures with a maximum depth of up to 125 µm (see Figure 3e). A main target for this method is imaging of the vasculature, targeting e.g. hemoglobin and oxygen saturation or immune dynamics in the pulmonary microvasculature (see e.g.
3 Micro computed tomography
With the complications of creating a 3D image volume from 2D sections detailed above or the limited imaging depth in the case of surface imaging, an alternative imaging technology that natively supports 3D imaging, like the micro computed tomography (µCT), seems advantageous. It facilitates the destruction-free imaging of complete organs (see e.g. Schambach et al. (2010)). Tissue can be treated with e.g. osmium tetroxide (OsO4) or phosphotungstic acid (PTA) to achieve the contrast levels necessary for analysis (Metscher, 2009; Quintarelli et al., 1971). See Figure 4a for a volume rendering of the µCT scan of a left mouse lung stained with PTA.
Figure 4

Full µCT volume image of the left mouse lung from Figure 1. (a) 3D volume rendering of a complete organ µCT scan stained with PTA. (b) Same as (a), but including a segmentation of the conducting airways. (c) Same as (b), but with the segmentation color coded for Strahler orders. (d) 2D image slice from the volume with Strahler order markings. See Figure 5 for details. Scale bar = 1000 µm. Strahler orders, counting from distal to proximal: Red = 1, green = 2, blue = 3, yellow = 4, cyan = 5, magenta = 6, white = 7.
The image stack resulting from a µCT scan can be segmented to create models of structures of interest, e.g. the airway-tree (see Figure 4b) or pulmonary blood vessels. Available methods are manual tracing of the structures (using e.g. Kremer et al., 1996), semi-automated approaches using threshold algorithms like watersheds (Meyer and Beucher, 1990) in combination with manual interaction (
The resulting segmentation images can then be analyzed for branching patterns and color coded accordingly. Different branching metrics have been established, e.g. standard generations (Weibel, 1963) or orders (
While the methods listed above are applicable for any structure with a tree-like branching pattern, airways can also be classified by anatomical nomenclature (Thoracic Society, 1950). Work has been conducted on adapting this nomenclature to the mouse lung and branching pattern phenotypes in different mouse breeds have been identified using µCT scans (Thiesse et al., 2010). This approach has its advantages in assessing variance in branching patterns and the comparison of individual central airway branches. For the task of identifying morphologically homogeneous groups of airway segments, it performs analogous to the standard generation approach.
Overlayed on the µCT image stack, the color-coded segmentation images can serve as a location indicator for adjacent structures that are analyzed, like the walls of airways or pulmonary vasculature (Labode et al., 2023). In addition, the morphology of the segmented structure itself can be analyzed for parameters such as total volume, number of bifurcations and segments, individual segment length (
The main drawback of µCT is the limited achievable resolution compared to light microscopy. There is a trade-off between field of view and resolution. While nanometer resolutions can be achieved for small tissue sections, in-vitro imaging of small animal organs delivers voxel sizes between about 5 µm and 10 µm (
Figure 5

PTA-stained tissue section roughly equal to the location of Figure 1, imaged using µCT. Discrepancies between the images are caused by the difference in physical cutting angle and the orientation of the organ within the µCT volume. The white lines in the top corners are imaging artifacts caused by the edge of the surrounding paraffin block. Scale bar = 1000 µm. Inset: Airway cross section (center). While the border of the airway is identifiable, its cellular composition is beyond reach. Scale bar = 50 µm.
The ability to mark specific structures, that is available in LM images using e.g. multi-colored stains, is very limited in the monochromatic µCT images. Options include the pairing of e.g. gold nanoparticles with antibodies to be used as markers in preclinical and clinical CT imaging (
For intracellular processes like apoptosis, radiotracers are available, but these require positron emission tomography to visualize. They are used e.g. for assessing chemotherapy results in cancer patients (
4 Multi step imaging pipelines
4.1 Established workflows
Due to the limitations of the imaging methods listed above, there have been efforts to combine multiple imaging techniques into one analysis workflow to profit from their individual advantages.
The workflow, as illustrated in Figure 6, is composed of the following steps: The organ is instilled with 4% paraformaldehyde (PFA) in situ, then harvested, and kept in PFA until it is contrasted for µCT as described above. It is then embedded in the embedding medium used for the following microtome cutting steps (e.g. paraffin, epoxy resin) and subsequently scanned to create an undisturbed 3D volume image. This order of preparation steps assures identical conditions for µCT and LM and thus limits the need for corrections in the registration process. On this dataset, the segmentation of the structure of interest (e.g. airway tree, pulmonary vasculature) is then conducted and further analyzed, as well as marked for e.g. branching order. In parallel, the LM-imaging is performed. To minimize the amount of material collected, while also ensuring unbiased results, a systematic uniform random sampling (SURS) (
Figure 6

Workflow for the combination of µCT and LM data. This is a generalized version of the design by
This technique has been used in BPD models to assess both pulmonary vasculature, as well as the airways in a location dependent fashion for both coarse morphology and cellular features (Labode et al., 2023; Pfleger et al., 2025) and has proven to be an invaluable tool for inter-group comparison in preclinical studies.
Reiser et al. (2025) demonstrated a pipeline incorporating even more imaging modalities, adding SRµCT and scanning electron microscopy (SEM). In addition, they scaled their process for a porcine lung, roughly equal in dimensions to a human lung. The whole organ was formalin fixed and paraffin embedded and subsequently scanned using SRµCT. Based on this first scan, regions of interest were extracted per punch biopsy and scanned in higher resolution. From these tissue cores, targeted areas where then sliced on a microtome and imaged using LM. Subareas of these slides were afterwards imaged using SEM. There was no comprehensive segmentation of e.g. airways from trachea down to alveoli, instead, limited segmentations of structures of interest were performed. The core biopsies were also not registered to the full lung scan. However, registrations between biopsy core µCT and LM and also between LM and SEM were performed. This allowed tracing of structures from the biopsy cores down to the SEM resolution level.
Salg et al. (2024) also worked on porcine tissue. While aimed at the pancreas, the general concepts of their workflow where in part inspired by and are applicable to lung research as well. In their setup, the blood vessels of the target organ were perfused with a contrast agent while still in-situ. The imaging pipeline then consisted of a clinical full body CT and subsequent higher resolution full organ ex-vivo scans and sub-organ level scans (µCT and SRµCT). A section of the blood vessels in a high-resolution scan were then segmented and analyzed for branching patterns. The workflow however did not include any image registrations between the different imaging modalities. So, no exact tracing of e.g. major blood vessels in the overview images into the high resolution sub-organ images was possible.
4.2 Integration of immunohistochemical markers
In the context of cell specific alterations, the assessment of intracellular processes is important. Previous multi step imaging pipelines however did not specifically try to include this and instead relied on basic histological stains for the purpose of the location specific assessment of cellular morphology. We thus present a novel extension to the workflow designed by
Two distinct techniques need to be differentiated in this context. Immunohistochemistry (IHC) marks proteins by using specific antibodies binding to them. These antibodies can be visualized either by coupling them to an enzyme that catalyzes a color producing reaction or by coupling them to a fluorophore. The latter option is termed immunofluorescence (IF). To visualize the fluorophore, it needs to be excited with light of a specific wavelength and will in turn emit a different wavelength of light (
As the IHC process is compatible with histological standard stains (see e.g. Ramos-Vara, 2005), there is no inherent need to adjust the registration process between the individual LM slices or the LM image stack and the µCT volume image. Only if the labeling adds too much signal fluctuation between individual LM slices or creates signal patterns greatly differing from the µCT image, some thresholding of the image intensity may be needed.
If IF is to be used, the necessary adaptions to the workflow are more extensive. From the established method of correlative light and electron microscopy it is known, that an OsO4 treatment can reduce the intensity of a number of fluorescent proteins. Furthermore, epoxy resin used for embedding can exhibit levels of autofluorescence that might compete with the intended fluorescent signal (Kopek et al., 2017; Tanida et al., 2024). Therefore, other contrast agents, such as PTA and embedding materials like paraffin or methacrylate should be used. For the registration between µCT and IF images, either a general tissue marker, e.g. wheat germ agglutinin (WGA) for epithelial cell surface (
Once the registration process is completed for either method, the registered segmentation overlay can be combined with different imaging modalities as needed. For the example presented here, a left mouse lung has been stained with PTA overnight in addition to the regular histological preparation and was afterwards embedded in paraffin and scanned in a µCT machine (Phoenix Nanotom, Waygate Technologies, Germany). This is arguably a high-end device that may be prohibitively expensive for some institutes. However, previous studies (
The resulting volume image, with an isometric voxel size of 6.67 µm (Figure 4a), was segmented using a nn-Unet (
After the µCT scan, sections were cut from the tissue block and the paraffin was removed using xylol. Staining with a pro-SP-C marker was performed overnight and a WGA stain was afterwards applied for two hours. The sectioning on a microtome required about half an hour per stack of 24 slices. How many stacks are necessary depends on organ size and sampling scheme, which in turn depends on the features of interest. An example for a sampling scheme, taken from Labode et al. (2023), would be to collect 24 consecutive slices of 4 µm thickness every 300 µm. For two rabbit lungs, this resulted in 14 and 17 stacks respectively, equal to roughly one work day of preparation time each. Reducing the section thickness to 2 µm and the distance between stacks to 100 µm, increased the workload by a factor of about 1.5.
The resulting histological slides then needed to be digitized. For this task, a Zeiss Axioscan Z1 (Zeiss, Göttingen, Germany) microscopic slide scanner was used. It can perform both bright-field and fluorescent imaging, processes up to 100 slides at a time, and can handle multiple organ slices on one glass slide (depending on organ size, two to three slices will fit on one slide). Scan times will mainly depend on the size of the slices and the magnification setting. The scan time for IF slices will depend on the number of markers employed, i.e. two markers require two scanning cycles with different wavelengths of light, equaling double the time required for a comparable bright-field image acquisition. The scan process is fully autonomous, and a rough estimate for the scan duration is overnight, i.e. the scanner can be loaded with the slides in the afternoon and unloaded the next morning. Simpler camera/microscope setups can be used as well, with the trade-off of an increased manual workload. Due to the high sensitivity of the IF stains to external stressors, the slides should be kept away from light sources and may be refrigerated until imaging. The time between staining and imaging should be kept to a minimum, i.e. hours rather than days.
In the following registration process, using the software elastix (Klein et al., 2010; Shamonin, 2013), the µCT volume image was transformed to achieve the highest possible fit with the IF image. Figure 7 illustrates the individual steps. Using the registration parameters resulting from this operation, the segmentation image could be adjusted in the same way and was then superimposed on top of the corresponding IF-section. The results are visualized in Figure 8, additional 3D context from the µCT is supplied in Figure 9. Image registration between the individual slices of a single stack again required two to three hours per stack. Here, in some cases, the result was deemed unsatisfactory and the images were adjusted (they were e.g. manually rotated, artifacts were digitally removed from the images or they were excluded if damages sustained in the cutting process were too severe for registration). In such a case, the registration job for the stack had to be rerun after the adjustments. The last preparation task was the registration between µCT and LM/IF stack. Here, the time per stack was roughly equal to the previous registration task. In some cases, the spatial position of the stack in relation to the full organ volume needed adjustment and repeated execution. All computational jobs required little to no manual interaction at runtime. They could be scripted to run in an efficient manner and quality control could be performed at opportune times. Thus, the manual work spent on these tasks was only a fraction of the compute times.
Figure 7

Steps of the registration process. While the result is not perfect (mostly due to the damages the IF slice, sustained in the cutting and preparation process), the segmentation overlay allows for a clear order attribution. (a) Pro-SPC channel of the IF image. (b) WGA channel of the IF image. (c) Autofluorescence channel of the IF image. Chosen for the registration, as its signal pattern most closely resembles that of the µCT image shown in (d). (d) µCT image stack translated laterally, z-position approximately matching that of the IF image in (c). This is the starting point for the registration process. (e) Registration result: The µCT image stack has been rotated in all three dimensions to achieve the highest overlap of features with the IF image. (f) The registration parameters resulting from (e) have been applied to the segmentation image (see Figures 4c,d). The result has been overlayed on the IF image (c). Scale bars = 1000 µm.
Figure 8

WGA (red) and pro-SP-C (green) channels of the IF image from Figures 7a–c, f, combined with the segmentation image. Scale bar = 1000 µm. Inset: The arrow points at a pro-SP-C positive cell in the airway. In a study setting, this would present a counting event for order 1. Scale bar = 50 µm.
Figure 9

µCT image slices combined with the 3D segmentation image. The arrow points at the region visible in the inset of Figure 8.
In the resulting images (Figures 7, 8), the WGA stain marks all cell borders, while the pro-SP-C marker highlights specific cells containing SP-C. Labeled cells in the airways are broncho-alveolar stem cells that are characteristic for the transitional zone between bronchiole and alveoli. In the alveolar region, type two pneumocytes are marked (see
While a marker for cell death would have been preferable in the context of this review, such a demonstration would have required fresh sample material from a lung injury model. Due to the ethical concerns raised by such models, appropriate material is scarce and was not available at the time of writing. While normal cell turnover and thus cell death is present in adult lungs, rates are so low, that witnessing such an event in the sampled region is a chance encounter. Therefore, the pro-SP-C marker was used for this demonstration, as it is a well-established and robust marker for proteins, that are present in a physiological state of the lung. Nevertheless, the demonstration presented here serves as a proof of concept to illustrate the possibility to integrate IF imaging into the existing workflow. In an appropriate model setting, this procedure can be performed in an analogous fashion with different markers, such as one of the well-established cleaved caspase 3 or 9 markers for apoptosis (see e.g.
When designing a study using the workflow proposed above, researchers can fine tune the setup to their requirements. The most basic decision however, is the choice of the immunohistochemical marking approach. Hence, some advantages and disadvantages to consider will be discussed here. IHC is easier to incorporate into the imaging process, as it requires only regular LM images. It also allows for simultaneous assessment of tissue morphology using the standard stain and histochemical processes marked by the enzyme. This facilitates the direct correlation of morphological and chemical alterations in the tissue. Stains are also more robust against e.g. photobleaching. IF on the other hand is more delicate, in that it fades rapidly and can be degraded by light exposure, e.g. in the imaging process. Thus, samples may require a quick succession of staining and imaging, special storage conditions and may not allow for repeat imaging. Additional image modalities for the registration process (i.e. a general marker in addition to the specific protein marker) can be necessary as well. This implies additional staining steps, as well as imaging time. Nevertheless, the IF approach excels, when only small amounts of the target protein are present, that might be hard to recognize in a basic IHC application. Additionally, multiple markers in different wavelength can be employed simultaneously, allowing for the detection of different substances in the same tissue section.
A main feature of the workflow presented here, is the reference of findings by their position along the airway tree. This element is important for the translation of study results between lungs of animals and humans. How such a translation can be performed, is highly dependent on the animal used and the structures of interest. Therefore, only some general aspects, examples and limitations, not an exhaustive description, can be provided here. One main factor to consider is the branching pattern of the airways. In human lungs, they branch out in a relatively symmetrical fashion, with each airway branch producing two morphologically similar daughter branches upon division (Weibel, 2009). Common lab animals on the other hand exhibit a highly asymmetrical, so called monopodial, branching pattern, characterized by a long central airway with significantly smaller lateral branches (Phalen and Oldham, 1983). This asymmetry is the reason, why a generation attribution is not practical in these lungs (see Labode et al., 2022). Therefore, when e.g. comparing coarse morphology, the airway sections of order six and seven in the mouse lung, as displayed in Figures 4c, d, are the structures most closely resembling the larger bronchi (first few generations) of the human lung.
However, beyond the difference in branching pattern, further structural disparities are present, that will influence the translation between species. For example, cartilage or mucus glands, as found in the human bronchi, are not present in mice, rats or rabbits. Furthermore, goblet cells e.g. in the rabbit are only found in the most proximal airways (
When studying the gas exchange region, it needs to be taken into account, that mice or rabbits do not, or only in rare cases, possess respiratory bronchioles (
Finally, a discussion of workflow limitations is in order. These inherently include the limitations of LM and µCT, which have been listed above. In their combination however, additional aspects, such as the achievable combined resolutions need to be considered. The extent of the segmentation markings extracted from the µCT image, used for reference purposes, is limited by the µCT resolution. In small animals, such as mice or rabbits, the conducting airways can be segmented without issue. The gas exchange region however cannot be sufficiently resolved. Previous BPD-studies for example measured mean alveolar septum thicknesses below 10 µm in the mouse (
The sequential use of both imaging techniques is also susceptible to changes to the tissue between the µCT imaging and LM imaging step, as those hinder the registration between both imaging modalities or in the creation of the LM image stacks. However, while a low number of slices or stacks might have to be excluded from analysis, a representative number of stacks has been reached by a high margin in the studies where this procedure has been employed in the past. Another obstacle that this approach can encounter, is airway or vessel collapse due to low instillation/perfusion pressure or blockage by an artifact in the preparation process. This would make a segmentation of the affected structure unfeasible. The reference of the occurrence of features by their location along the airway- or vessel tree, that is central to the presented method, would thus be prevented. Care must therefore be taken in the initial organ preparation steps.
5 Summary and outlook
Both LM and µCT are important tools for studying the lung. Nevertheless, for the location specific analysis of cellular alterations, a combination of both imaging modalities, delivers the most conclusive results. Several studies have presented multi-step imaging pipelines, that successfully integrated different imaging modalities, to combine high resolution images with full organ spatial references. It could further be demonstrated, that such a workflow can be adapted to complex research questions, where not only morphology is important, but also the identification of intracellular processes using IHC or IF. This method can therefore serve as an important tool for further researching the role of cell death in BPD. Its use in future studies may provide information about how the location of acute cell stress and cell death relates to the location of chronic changes that manifest and persist in the lung tissue later in life. The identification of main drivers, i.e. intracellular processes that show the highest correlation with morphological changes may be possible, in turn identifying potential targets for treatment approaches. It can support addressing a main issue of preclinical models of lung disease, by aiding contextualized data collection and advance the translation of results to the morphology of the human lung.
Broadening the view, the general research goal should be to combine knowledge of pathology manifestation, gathered from both clinical and preclinical research, to a conclusive model of what drives disease progression at which time and at what location. An important aspect that needs further research is the translation of the site of pathological changes in preclinical animal models, where lung morphology (e.g. a monopodial branching pattern) and airway characteristics (no bronchus with cartilage or glands is present in mice or rabbits) differ from the human lung they are supposed to represent.
While this review focused on lung pathology research, it should nevertheless be mentioned, that the methods of location specific histology can be applied to other research questions, such as treatment strategies, as well. Once targets for pharmaceutical intervention are identified, a way for optimal drug delivery needs to be formulated. Here, the discussed workflow could be essential to identify e.g. particle deposition patterns of inhaled pharmaceuticals in respect to the branching morphology of the targeted lung.
With imaging technology further advancing and enabling increasingly deeper and more comprehensive insights into the lung, techniques that allow locating that information within the structure of the organ and facilitate the identification of representative sampling locations, increasingly gain in importance.
Statements
Author contributions
JL: Writing – original draft, Software, Investigation, Writing – review & editing, Data curation, Validation, Visualization, Conceptualization, Methodology, Formal analysis. CM: Funding acquisition, Validation, Conceptualization, Project administration, Writing – review & editing, Supervision, Methodology.
Funding
The author(s) declared that financial support was received for this work and/or its publication. The study was funded by the DFG (grants MU 3118/8-1, 501811684) and the German Center for Lung Research (grant 82DZL002C1).
Acknowledgments
The authors thank Susanne Kuhlmann, Stefanie Beensen and Melanie Bornemann for their role in preparing the organ samples and Julia Schipke and Franziska Matthias for their support in the creation of the IF images. µCT data was generated by use of the Research Core Unit Electron Microscopy, Hannover Medical School. The authors acknowledge the Hannover Medical School for providing MHH-HPC resources and technical support that have contributed to the research results reported within this paper.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbbeE. (1873). Beitrage zur theorie des mikroskops und der mikroskopischen wahmehmung. Archiv Ftir Mikroskopische Anatomie9, 413–468. doi: 10.1007/bf02956173
2
AbmanS. H. (2008). The dysmorphic pulmonary circulation in bronchopulmonary dysplasia. Am. J. Resp. Crit. Care178, 114–115. doi: 10.1164/rccm.200804-629ed
3
AkramK. M.YatesL. L.MongeyR.RotheryS.GaboriauD. C. A.SandersonJ.et al. (2019). Live imaging of alveologenesis in precision-cut lung slices reveals dynamic epithelial cell behaviour. Nat. Commun.10, 1178. doi: 10.1038/s41467-019-09067-3
4
Alizadeh-TabriziN.HallS.LehmannC. (2021). Intravital imaging of pulmonary immune response in inflammation and infection. Front. Cell Dev. Biol.8. doi: 10.3389/fcell.2020.620471
5
AppuhnS. V.SiebertS.MytiD.WredeC.SolaligueD. E. S.Perez-BravoD.et al. (2021). Capillary changes precede disordered alveolarization in a mouse model of bronchopulmonary dysplasia. Am. J. Respir. Cell Mol. Biol.65, 81–91. doi: 10.1165/rcmb.2021-0004oc
6
AshtonJ. R.WestJ. L.BadeaC. T. (2015). In vivo small animal micro-ct using nanoparticle contrast agents. Front. Pharmacol.6. doi: 10.3389/fphar.2015.00256
7
BadeaC. T.DrangovaM.HoldsworthD. W.JohnsonG. A. (2008). In vivo small-animal imaging using micro-ct and digital subtraction angiography. Phys. Med. Biol.53, R319–R350. doi: 10.1088/0031-9155/53/19/r01
8
BanerjiR.GrifnoG. N.ShiL.SmolenD.LeBourdaisR.MuhvichJ.et al. (2023). Crystal ribcage: a platform for probing real-time lung function at cellular resolution. Nat. Methods. 20, 1790–1801. doi: 10.1038/S41592-023-02004-9
9
BarnesP. J. (1990). Reactive oxygen species and airway inflammation. Free Radical Bio. Med.9, 235–243. doi: 10.1016/0891-5849(90)90034-g
10
BarrancoI.Gomez-LagunaJ.Rodnguez-GomezI. M.SalgueroF. J.PallaresF. J.BemabeA.et al. (2011). Immunohistochemical detection of extrinsic and intrinsic mediators of apoptosis in porcine paraffin-embedded tissues. Vet. Immunol. Immunop.139, 210–216. doi: 10.1016/j.vetimm.2010.10.017
11
BernR. A.van der LoosC. M.van WoenselJ. B. M.BosA. P. (2010). Cleaved caspase-3 in lung epithelium of children who died with acute respiratory distress syndrome. Pediatr. Crit. Care Med.11, 556–560. doi: 10.1097/pcc.0b013e3181d5063c
12
BeroskeL.Van den WyngaertT.StroobantsS.Van der VekenP.ElvasF. (2021). Molecular imaging of apoptosis: the case of caspase-3 radiotracers. Int. J. Mol. Sci.22, 3948. doi: 10.3390/ijms22083948
13
BushD.JulianoC.BowlerS.TiozzoC. (2023). Development and disorders of the airway in bronchopulmonary dysplasia. Children10, 1127. doi: 10.3390/children10071127
14
ChazotteB. (2011). Labeling membrane glycoproteins or glycolipids with fluorescent wheat germ agglutinin. Cold Spring Harb. Protoc.2011, pdb.prot5623. doi: 10.1101/pdb.prot5623
15
ClearyS. J.QiuL.SeoY.BalukP.LiuD.SerwasN. K.et al. (2024). Intravital imaging of pulmonary lymphatics in inflammation and metastatic cancer. doi: 10.1101/2024.09.12.612619
16
CoalsonJ. J. (2003). Pathology of new bronchopulmonary dysplasia. Semin. Neonatol.8, 73–81. doi: 10.1016/s1084-2756(02)00193-8
17
DaetwylerS.FiolkaR. P. (2023). Light-sheets and smart microscopy, an exciting future is dawning. Commun. Biol.6, 502. doi: 10.1038/s42003-023-04857-4
18
Del ValleL. (Ed.) (2022). Immunohistochemistry and Immunocytochemistry: Methods and Protocols (New York, NY: Springer US). doi: 10.1007/978-1-0716-1948-3
19
DengX.BaoZ.YangX.MeiY.ZhouQ.ChenA.et al. (2022). Molecular mechanisms of cell death in bronchopulmonary dysplasia. Apoptosis28, 39–54. doi: 10.1007/s10495-022-01791-4
20
DoughertyR.KunzelmannK.-H. (2007). Computing local thickness of 3d structures with imagej. Microsc. Microanal.13, 1678–1679. doi: 10.1017/s1431927607074430
21
DuanW. R.GamerD. S.WilliamsS. D.Funckes-ShippyC. L.SpathI. S.BlommeE. A. (2003). Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the tunel method for quantification of apoptosis in histological sections of pc-3 subcutaneous xenografts. J. Pathol.199, 221–228. doi: 10.1002/path.1289
22
EenjesE.TibboelD.WijnenR. M.RottierR. J. (2022). Lung epithelium development and airway regeneration. Front. Cell Dev. Biol.10. doi: 10.3389/fcell.2022.1022457
23
GeubbelmansM.ClaesJ.NijstenK.GervoisP.AppeltansS.MartensS.et al. (2024). Optimization of whole slide imaging scan settings for computer vision using human lung cancer tissue. PLoS One19, e0309740. doi: 10.1371/journal.pone.0309740
24
GrifnoG. N.KahveciogluH. A.LeBourdaisR.TravnikV.BanerjiR.WangsrikhunW.et al. (2025). Mosaic pattern: lung functional heterogeneity at the alveolus level. doi: 10.1101/2025.10.13.682072
25
GrothausmannR. (2015). Click’n’ join-mode extension to itk - snap in cuding global, dynamic watershed segmentation. Available online at: https://github.com/pyushkevich/itksnap/pull/1 (Accessed December 10, 2024).
26
GrothausmannR.KnudsenL.OchsM.MuhlfeldC. (2017). Digital 3d reconstructions using histological serial sections of lung tissue including the alveolar capillary network. Am. J. Physiol-Lung C.312, L243–L257. doi: 10.1152/ajplung.00326.2016
27
GrothausmannR.LabodeJ.Hemandez-CerdanP.HaberthiirD.HlushchukR.LobachevO.et al. (2021). Combination of pet and light microscopy for generation-specific stereological analysis of pulmonary arterial branches: a proof-of-concept study. Histochem. Cell Biol.155, 227–239. doi: 10.1007/s00418-020-01946-x
28
GundersenH. J. G.JensenE. B. (1987). The efficiency of systematic sampling in stereology and its prediction. J. Microsc.147, 229–263. doi: 10.1111/j.1365-2818.1987.tb02837.x
29
HannaG.FontanellaA.PalmerG.ShanS.RadiloffD. R.ZhaoY.et al. (2013). Automated measurement of blood flow velocity and direction and hemoglobin oxygen saturation in the rat lung using intravital microscopy. Am. J. Physiol. Lung Cell. Mol. Physiol.304, L86–L91. doi: 10.1152/ajplung.00178.2012
30
HansmannG.SallmonH.RoehrC. C.KourembanasS.AustinE. D.andM. K. (2020). Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr. Res.89, 446–455. doi: 10.1038/s41390-020-0993-4
31
HastieT.TibshiraniR.FriedmanJ. (2009). The Elements of Statistical Learning (New York, NY: Springer New York). doi: 10.1007/978-0-387-84858-7
32
Hemandez-CerdanP. (2021). Sgext: Spatial graph extractor. Geneva: Zenodo. doi: 10.5281/ZENODO.5040457
33
HewitsonT. D.DarbyI. A. (Eds.) (2010). Histology Protocols (Totowa, NJ: Humana Press). doi: 10.1007/978-1-60327-345-9
34
HillD. L. G.BatchelorP. G.HoldenM.HawkesD. J. (2001). Medical image registration. Phys. Med. Biol.46, R1–R45. doi: 10.1088/0031-9155/46/3/201
35
HislopA. A.HaworthS. G. (1989). Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artificial ventilation. Am. Rev. Respir. Dis.140, 1717–1726. doi: 10.1164/ajrccm/140.6.1717
36
HorsfieldK. (1984). Axial pathways compared with complete data in morphological studies of the lung. Resp. Physiol.55, 317–324. doi: 10.1016/0034-5687(84)90054-9
37
HsuJ. C.NievesL. M.BetzerO.SadanT.NoelP. B.PopovtzerR.et al. (2020). Nanoparticle contrast agents for x-ray imaging applications. WIREs Nanomed. Nanobiotechnol.12, e1642. doi: 10.1002/wnan.1642
38
HuiskenJ.SwogerJ.Del BeneF.WittbrodtJ.StelzerE. H. K. (2004). Optical sectioning deep inside live embryos by selective plane illumination microscopy. Science305, 1007–1013. doi: 10.1126/science.1100035
39
HuppertzB.FrankH.-G.KaufmannP. (1999). The apoptosis cascade - morphological and immunohistochemical methods for its visualization. Anat. Embryol.200, 1–18. doi: 10.1007/S004290050254
40
HydeD. M.MillerL. A.SchelegleE. S.FanucchiM. V.Van WinkleL. S.TylerN. K.et al. (2006). Asthma: a comparison of animal models using stereological methods. Eur. Respir. Rev.15, 122–135. doi: 10.1183/09059180.00010103
41
IrvinC. G.BatesJ. H. (2003). Measuring the lung function in the mouse: the challenge of size. Respir. Res.4, 1. doi: 10.1186/rr199
42
IsenseeF.JaegerP. F.KohlS. A. A.PetersenJ.Maier-HeinK. H. (2020). nnU-Net: a selfconfiguring method for deep learning-based biomedical image segmentation. Nat. Methods18, 203–211. doi: 10.1038/s41592-020-01008-z
43
JoshiS.YuD. (2017). Immunofluorescence (Cambridge: Elsevier), 135–150. doi: 10.1016/b978-0-12-803077-6.00008-4
44
Kaarteenaho-WiikR.KinnulaV. L. (2004). Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. J. Histochem. Cytochem.52, 1231–1240. doi: 10.1369/jhc.4a6291.2004
45
KamaruzamanN. A.KardiaE.KamaldinN. A.LatahirA. Z.YahayaB. H. (2013). The rabbit as a model for studying lung disease and stem cell therapy. BioMed. Res. Int.2013, 1–12. doi: 10.1155/2013/691830
46
KanwalN.Perez-BuenoF.SchmidtA.EnganK.MolinaR. (2022). The devil is in the details: whole slide image acquisition and processing for artifacts detection, color variation, and data augmentation: a review. IEEE Access10, 58821–58844. doi: 10.1109/access.2022.3176091
47
KeklikoglouK.FaulwetterS.ChatzinikolaouE.WilsP.BreckoJ.KvacekJ.et al. (2019). Micro-computed tomography for natural history specimens: a handbook of best practice protocols. Eur. J. Taxon.522. doi: 10.5852/ejt.2019.522
48
KimC. F. B.JacksonE. L.WoolfendenA. E.LawrenceS.BabarI.VogelS.et al. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell.121, 823–835. doi: 10.1016/j.cell.2005.03.032
49
KleinS.StaringM.MurphyK.ViergeverM.PluimJ. (2010). elastix: a toolbox for intensity-based medical image registration. IEEE Trans. Med. Imaging29, 196–205. doi: 10.1109/tmi.2009.2035616
50
KopekB. G.Paez-SegalaM. G.ShtengelG.SochackiK. A.SunM. G.WangY.et al. (2017). Diverse protocols for correlative super-resolution fluorescence imaging and electron microscopy of chemically fixed samples. Nat. Protoc.12, 916–946. doi: 10.1038/nprot.2017.017
51
Koziol-WhiteC.GebskiE.CaoG.PanettieriR. A. (2024). Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery. Respir. Res.25, 231. doi: 10.1186/s12931-024-02855-6
52
KremerJ. R.MastronardeD. N.McIntoshJ. (1996). Computer visualization of three-dimensional image data using imod. J. Struct. Biol.116, 71–76. doi: 10.1006/jsbi.1996.0013
53
KumaraswamyK.ArchanaM.BastianYogeshT. (2013). Various methods available for detection of apoptotic cells- a review. Indian J. Cancer50, 274. doi: 10.4103/0019-509x.118720
54
KuwanoK.HagimotoN.MaeyamaT.FujitaM.YoshimiM.InoshimaI.et al. (2002). Mitochondria- mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab. Investig.82, 1695–1706. doi: 10.1097/01.lab.0000045084.81853.76
55
LabodeJ.DullinC.WagnerW. L.MytiD.MortyR. E.MühlfeldC. (2022). Evaluation of classifications of the monopodial bronchopulmonary vasculature using clustering methods. Histochem. Cell Biol. 158, 435–445. doi: 10.1007/s00418-022-02116-x
56
LabodeJ.HaberthtirD. (2024). labode/genana_py: initial release. Geneva: Zenodo. doi: 10.5281/ZENODO.14381619
57
LabodeJ.HaberthtirD.HlushchukR.ReginY.GieA.SalaetsT.et al. (2023). Location-specific pathology analysis of the monopodial pulmonaryvasculature in a rabbit model of bronchopulmonary dysplasia - a pilot study. Physiol. Rep.11, e15747. doi: 10.14814/phy2.15747
58
LeBourdaisR.GrifnoG. N.BanerjiR.ReganK.SukiB.NiaH. T. (2024). Mapping the strain-stiffening behavior of the lung and lung cancer at microscale resolution using the crystal ribcage. Front. Netw. Physiol.4. doi: 10.3389/fnetp.2024.1396593
59
LeeR. M. K. W.O’BrodovichH. (1988). Airway epithelial damage in premature infants with respiratory failure. Am. Rev. Respir. Dis.137, 450–457. doi: 10.1164/ajrccm/137.2.450
60
LiuG.BettsC.CunoosamyD. M.AbergP. M.HombergJ. J.SivarsK. B.et al. (2019). Use of precision cut lung slices as a translational model for the study of lung biology. Respir. Res.20, 162. doi: 10.1186/s12931-019-1131-x
61
LooneyM. R.ThorntonE. E.SenD.LammW. J.GlennyR. W.KrummelM. F. (2010). Stabilized imaging of immune surveillance in the mouse lung. Nat. Methods8, 91–96. doi: 10.1038/nmeth.1543
62
Lyons-CohenM. R.NakanoH.ThomasS. Y.CookD. N. (2018). “ Imaging precision-cut lung slices to visualize leukocyte localization and trafficking,” in Imaging Precision-Cut Lung Slices to Visualize Leukocyte Localization and Trafficking (New York, NY: Springer New York), 237–246. doi: 10.1007/978-1-4939-7896-0_18
63
MarisL.GokerM.DebackerJ. M.De ManK.Van den BroeckB.Van DorpeJ.et al. (2024). Method for co-registration of high-resolution specimen pet-ct with histopathology to improve insight into radiotracer distributions. EJNMMI Phys.11, 85. doi: 10.1186/s40658-024-00681-9
64
MetscherB. D. (2009). MicroCT for comparative morphology: simple staining methods allow high-contrast 3d imaging of diverse non-mineralized animal tissues. BMC Physiol.9, 11. doi: 10.1186/1472-6793-9-11
65
MeyerF.BeucherS. (1990). Morphological segmentation. J. Vis. Commun. Image R.1, 21–46. doi: 10.1016/1047-3203(90)90014-m
66
MuhlfeldC.OchsM. (2013). Quantitative microscopy of the lung: a problem-based approach, part 2: stereological parameters and study designs in various diseases of the respiratory tract. Am. J. Physiol-Lung C.305, L205–L221. doi: 10.1152/ajplung.00427.2012
67
MuhlfeldC.SchulteH.JansingJ. C.CasiraghiC.RicciF.CatozziC.et al. (2021). Design-based stereology of the lung in the hyperoxic preterm rabbit model of bronchopulmonary dysplasia. Oxid. Med.Cell. Longev.2021, 4293279. doi: 10.1155/2021/4293279
68
OchsM.KnudsenL.HegermannJ.WredeC.GrothausmannR.MuhlfeldC. (2016). Using electron microscopes to look into the lung. Histochem. Cell Biol.146, 695–707. doi: 10.1007/s00418-016-1502-z
69
OchsM.MuhlfeldC. (2013). Quantitative microscopy of the lung: a problem-based approach, part 1: basic principles of lung stereology. Am. J. Physiol-Lung C.305, L15–L22. doi: 10.1152/ajplung.00429.2012
70
O’ReillyM. A.StaverskyR. J.StrippB. R.FinkelsteinJ. N. (1998). Exposure to hyperoxia induces p53 expression in mouse lung epithelium. Am. J. Resp. Cell. Mol.18, 43–50. doi: 10.1165/ajrcmb.18.1.2950m
71
PerlmanC. E.KnudsenL.SmithB. J. (2024). The fix is not yet in: recommendation for fixation of lungs within physiological/pathophysiological volume range in preclinical pulmonary structure-function studies. Am. J. Physiol-Lung C.327, L218–L231. doi: 10.1152/ajplung.00341.2023
72
PetracheI.FijalkowskaI.MedlerT. R.SkirballJ.CruzP.ZhenL.et al. (2006). a-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol.169, 1155–1166. doi: 10.2353/ajpath.2006.060058
73
PflegerY.BodeL. S. C.HaberthiirD.HlushchukR.ReginY.GieA. G.et al. (2025). Location- specific pathology analysis of monopodial airways in a rabbit model of bronchopulmonary dysplasia: a proof of principle study. BMC Med. Imaging25, 121. doi: 10.1186/s12880-025-01657-6
74
PhalenR. F.OldhamM. J. (1983). Tracheobronchial airway structure as revealed by casting techniques. Am. J. Respir. Crit. Care Med.128, S1–S4. doi: 10.1164/arrd.1983.128.2P2.S1
75
PlopperC. G.HalseboJ. E.BergerW. J.SonstegardK. S.NettesheimP. (1983). Distribution of nonciliated bronchiolar epithelial (clara) cells in intra- and extrapulmonary airways of the rabbit. Exp.Lung Res.5, 79–98. doi: 10.3109/01902148309061506
76
QuintarelliG.ZitoR.CifonelliJ. A. (1971). On phosphotungstic acid staining, i. J. Histochem. Cytochem.19, 641–647. doi: 10.1177/19.11.641
77
Ramos-VaraJ. A. (2005). Technical aspects of immunohistochemistry. Vet. Pathol.42, 405–426. doi: 10.1354/vp.42-4-405
78
ReiserJ.AlbersJ.SvetloveA.MertinyM.KommossF. K. F.SchwabC.et al. (2025). Integrated 3d imaging of fifpe lung tissue combining microct, light and electron microscopy allows for contextualized ultrastructural and histological analysis. Sci. Rep.15, 18656. doi: 10.1038/s41598-025-02770-w
79
RogersD. F. (2003). The airway goblet cell. Int. J. Biochem. Cell Biol.35, 1–6. doi: 10.1016/s1357-2725(02)00083-3
80
RonnebergerO.FischerP.BroxT. (2015). U-net: Convolutional networks for biomedical image segmentation. arXiv. doi: 10.48550/ARXIV.1505.04597
81
RybczynskaA. A.BoersmaH. H.de JongS.GietemaJ. A.NoordzijW.DierckxR. A. J. O.et al. (2018). Avenues to molecular imaging of dying cells: Focus on cancer. Med. Res. Rev.38, 1713–1768. doi: 10.1002/med.21495
82
SalgG. A.SteinleV.LabodeJ.WagnerW.Studier-FischerA.ReiserJ.et al. (2024). Multiscale and multimodal imaging for three-dimensional vascular and histomorphological organ structure analysis of the pancreas. Sci. Rep.14, 10136. doi: 10.1038/s41598-024-60254-9
83
SchambachS. J.BagS.SchillingL.GrodenC.BrockmannM. A. (2010). Application of micro-ct in small animal imaging. Methods50, 2–13. doi: 10.1016/j.ymeth.2009.08.007
84
ShamoninD. (2013). Fast parallel image registration on cpu and gpu for diagnostic classification of alzheimer’s disease. Front. Neuroinf.7. doi: 10.3389/fninf.2013.00050
85
StrahlerA. N. (1957). Quantitative analysis of watershed geomorphology. Eos38, 913–920. doi: 10.1029/tr038i006p00913
86
TanidaI.YamaguchiJ.MitsuiS.SanadaT.SuzukiC.KakutaS.et al. (2024). In-resin clem of epon-embedded cells and tissues: An approach for volume clem. Microsc. Microonal.30, ozae044.480. doi: 10.1093/mam/ozae044.480
87
TaqiS. A.SamiS. A.SamiL. B.ZakiS. A. (2018). A review of artifacts in histopathology. J. Oral. Maxillofac. Pathol.22, 279–279. doi: 10.4103/jomfp.jomfp_125_15
88
ThebaudB.GossK. N.LaughonM.WhitsettJ. A.AbmanS. H.SteinhomR. H.et al. (2019). Bronchopulmonary dysplasia. Nat. Rev. Dis. Primers5, 78. doi: 10.1038/s41572-019-0127-7
89
ThiesseJ.NamatiE.SierenJ. C.SmithA. R.ReinhardtJ. M.HoffmanE. A.et al. (2010). Lung structure phenotype variation in inbred mouse strains revealed through in vivo micro-ct imaging. J. Appl. Physiol.109, 1960–1968. doi: 10.1152/japplphysiol.01322.2009
90
Thoracic Society (1950). Nomenclature of broncho-pulmonary anatomy; an international nomenclature accepted by the thoracic society. Thorax5, 222–228. doi: 10.1136/thx.5.3.222
91
TiddensH. A.HofhuisW.CasottiV.HopW. C.HulsmannA. R.de JongsteJ. C. (2008). Airway dimensions in bronchopulmonary dysplasia: Implications for airflow obstruction. Pediatr. Pulm.43, 1206–1213. doi: 10.1002/ppul.20928
92
TyasL.BrophyV. A.PopeA.RivettA. J.TavareJ. M. (2000). Rapid caspase-3 activation during apoptosis revealed using fluorescence-resonance energy transfer. EMBO Rep.1, 266–270. doi: 10.1093/embo-reports/kvd050
93
van RijtS. H.BbltikbasD. A.ArgyoC.DatzS.LindnerM.EickelbergO.et al. (2015). Protease- mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors. ACS Nano9, 2377–2389. doi: 10.1021/nn5070343
94
VianaF.O’KaneC. M.SchroederG. N. (2021). Precision-cut lung slices: A powerful ex vivo model to investigate respiratory infectious diseases. Mol. Microbiol.117, 578–588. doi: 10.1111/mmi.14817
95
WangJ.DongW. (2018). Oxidative stress and bronchopulmonary dysplasia. Gene678, 177–183. doi: 10.1016/j.gene.2018.08.031
96
WangP. M.KramanS. S. (2004). Fractal branching pattern of the monopodial canine airway. J. Appl. Physiol.96, 2194–2199. doi: 10.1152/japplphysiol.00604.2003
97
WangL.YeY.SuH.YangJ. (2017). The anesthetic agent sevoflurane attenuates pulmonary acute lung injury by modulating apoptotic pathways. Braz. J. Med. Biol. Res.50, e5747. doi: 10.1590/1414-431x20165747
98
WeibelE. R. (1963). Morphometry of the Human Lung (Berlin: Springer Berlin Heidelberg). doi: 10.1007/978-3-642-87553-3
99
WeibelE. R. (2009). What makes a good lung? Swiss Med. Wkly.139, 375–386. doi: 10.4414/smw.2009.12270
100
WrightD. T.CohnL. A.LiH.FischerB.LiC. M.AdlerK. B. (1994). Interactions of oxygen radicals with airway epithelium. Environ. Health Persp.102, 85–90. doi: 10.1289/ehp.94102s1085
101
WyssC.SchaeferS. C.Juillerat-JeanneretL.LagopoulosL.LehrH.-A.BeckerC. D.et al. (2009). Molecular imaging by micro-ct: specific e-selectin imaging. Eur. Radiol.19, 2487–2494. doi: 10.1007/s00330-009-1434-2
102
XiaoA.GibbonsA. E.LukerK. E.LukerG. D. (2015). Fluorescence lifetime imaging of apoptosis. Tomography1, 115–124. doi: 10.18383/j.tom.2015.00163
103
YangL.FeuchtingerA.MöllerW.DingY.KutschkeD.MöllerG.et al. (2019). Three-dimensional quantitative co-mapping of pulmonary morphology and nanoparticle distribution with cellular resolution in nondissected murine lungs. ACS Nano. 13, 1029–1041. doi: 10.1021/acsnano.8b07524
104
YangL.KumarP.SenguptaA.FarnoudA.ShenR.TrofimovaD.et al. (2023). Multimodal imaging and deep learning unveil pulmonary delivery profiles and acinar migration of tissue-resident macrophages in the lung. Research Square. doi: 10.21203/rs.3.rs-2994336/v1
105
ZuoW.-L.ShenoyS. A.LiS.O'BeirneS. L.Strulovici-BarelY.LeopoldP. L.et al. (2018). Ontogeny and biology of human small airway epithelial club cells. Am. J. Resp. Crit. Care198, 1375–1388. doi: 10.1164/rccm.201710-2107oc
Summary
Keywords
apoptosis, branching analysis, bronchopulmonary dysplasia, immunohistochemistry, light microscopy, micro-computed tomography
Citation
Labode J and Mühlfeld C (2026) Methods to localize cell specific alterations within the 3D context of the lung. Front. Physiol. 17:1805715. doi: 10.3389/fphys.2026.1805715
Received
06 February 2026
Revised
22 June 2026
Accepted
30 June 2026
Published
15 July 2026
Volume
17 - 2026
Edited by
Renqiang Yu, Jiangnan University, China
Reviewed by
Doris Cerecedo, National Polytechnic Institute (IPN), Mexico
Soumya Mitra, AbbVie, United States
Updates

Check for updates
Copyright
© 2026 Labode and Mühlfeld.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jonas Labode, labode.jonas@mh-hannover.de
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.